GABARAP

Across TCGA pan-cancer cohorts, GABARAP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GABARAP data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher GABARAP Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated GABARAP expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

BLCA and SKCM are the cancer types where GABARAP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	II,III,IV	1.000	0.325	.021	22	view →
SKCM	DFS	Median	All	0.209	0.728	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

GABARAP–BLCA (DFS)

Open the BLCA breakdown →